{"id":"NCT01915823","sponsor":"Meda Pharmaceuticals","briefTitle":"Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)","officialTitle":"Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07","primaryCompletion":"2014-02","completion":null,"firstPosted":"2013-08-05","resultsPosted":"2015-06-29","lastUpdate":"2015-06-29"},"enrollment":348,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"azelastine hydrochloride and fluticasone propionate","otherNames":["Dymista"]},{"type":"DRUG","name":"Dymista vehicle","otherNames":["placebo"]}],"arms":[{"label":"Dymista","type":"ACTIVE_COMPARATOR"},{"label":"Dymista vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if Dymista nasal spray is better and safer than placebo in treating children ages 4 to \\<12 years old who have seasonal allergic rhinitis.","primaryOutcome":{"measure":"Primary Efficacy","timeFrame":"15 days of treatment","effectByArm":[{"arm":"Dymista","deltaMin":-3.83,"sd":5.154},{"arm":"Dymista Vehicle","deltaMin":-2.77,"sd":4.731}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":20},"locations":{"siteCount":31,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":173},"commonTop":["epistaxis","dysgusia"]}}